Browsing by Subject Hepatitis B Vaccines

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  

Showing results 1 to 20 of 48  next >
Are childhood immunization programmes in Australia at risk? Investigation of the cold chain in the Northern Territory / N. C. Miller & M. F. Harris
Miller, N. C; Harris, M. F ( 1994 )
A collaborative study of the proposed international reference preparation for hepatitis B vaccine containing plasma-derived hepatitis B surface antigen (HBsAg / by Morag Ferguson, Valerie Seagroat and Geoffrey C. Schild
Ferguson, Morag; Seagroatt, Valerie; Schild, Geoffrey Christopher; World Health Organization. Biologicals Unit ( 1986 )
Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity / G. M. Ginsberg, S. Berger, & D. Shouval
Ginsberg, G. M; Berger, S; Shouval, D ( 1992 )
The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia / Carol E. Levin .... [et al.]
Levin, Carol E; Nelson, Carib M; Widjaya, Anton; Moniaga, Vanda; Anwar, Chairiyah ( 2005 )
European Advisory Group on the Expanded Programme on Immunization (EAG/EPI) : report on the fourteenth meeting, London, United Kingdom 27-29 January 1998
WHO Expanded Programme on Immunization. European Advisory Group . Meeting (14th: 1998: London, United Kingdom); World Health Organization. Regional Office for Europe ( 1998 )

The EAG proposed targets and recommendations for the elimination of poliomyelitis, neonatal tetanus, indigenous diphtheria and measles, for reducing the carrier incidence of hepatitis B virus in children under five years, and for controlling mumps, pertussis, congenital rubella and invasive disease caused by Haemophilus influenzae type b. Achieving these targets would require appropriate political will, well defined strategies, the necessary managerial and financial resources, well organized public health systems with laboratory-based infectious diseases surveillance, high immunization coverage, national and international collaboration, and national immunization programmes that were sustainable and self-sufficient from the earliest possible date. The EAG agreed that poliomyelitis eradication remained the first priority for national elimination programmes. It believed, however, that measles elimination strategies needed to be accelerated and that an operational plan should be developed. The EAG agreed that hepatitis B prevention was a high priority. The Group recommended that all countries implement systems to monitor adverse events following immunization and safe immunization practices. The EAG was aware that public and professional concerns about vaccine safety would increase in both developed and developing countries, with the potential to seriously undermine confidence in immunization. The EAG considered that, subject to public health justifications for resource utilization, there could be useful roles for rotavirus and varicella vaccines in routine programmes. The Group recognized the advantages of new combination vaccines, but was also aware of some of their shortcomings. The EAG was appreciative of the progress towards poliomyelitis eradication in the Region, and endorsed the definition for classification of vaccine-associated paralytic poliomyelitis

Evaluation of the routine hepatitis B immunization programme in palestine, 1996
Kuhail, S.; El Khodary, R.; Ahmed, F. ( 2000 )

The objectives of this study were to evaluate routine hepatitis B immunization in Palestine. Blood samples of 119 children [89 fully immunized and 30 non-immunized] were analysed. The protective antibody levels among immunized children were greater than the non-immunized children. Antibody levels among the immunized children were lower in the older age group [> 36 months], but no sex differences in antibody level were apparent. Thus, hepatitis B immunization had an excellent impact on preventing hepatitis B transmission [85% preventive]. The non-responders constituted 14.6% of the sample, which is higher than other studies

Fourniture à domicile de vaccins thermostables en Indonésie : vaccination sur le terrain au moyen d' une seringue-dose préremplie jetable / A. Sutanto ... [et al.]
Sutanto, A; Suarnawa, I. M; Nelson, C. M; Stewart, T; Soewarso, Indijati T ( 1999 )
The Fourth Hepatitis B Expert Resource Panel Consultation, Hanoi, Viet Nam, 25-27 January 2016 : meeting report
World Health Organization. Regional Office for the Western Pacific ( 2015 )
Global policy report on the prevention and control of viral hepatitis in WHO Member States
World Health Organization ( 2013 )
Hepatitis B control through immunization : a reference guide
World Health Organization. Regional Office for the Western Pacific ( 2014 )
Hepatitis B immunization : introducing hepatitis B vaccine into national immunization services
World Health Organization. Dept. of Vaccines and Biologicals ( 2001 )
Hepatitis B vaccination coverage among Iranian children aged 15-26 months in 2006
Esteghamati, A.; Keshtkar, A.A.; Nadjafi, L.; Gouya, M.M.; Salaramoli, M.; Roshandel, Gh.; Yaghini, F. ( 2011 )

This study in 2006 estimated the hepatitis B virus [BHV] vaccination coverage in the Islamic Republic of Iran at the national and district levels in urban, rural and remote populations of 41 university health service areas. Of 21 905 children recruited to the study, vaccination coverage based on vaccination card records was 100% in 14,15 and 10 of the 41 university areas for the 1st, 2nd and 3rd doses of HBV respectively. National levels of HBV1, HBV2 and HBV3 coverage were 98.9%, 98.8% and 98.4% respectively. The lowest HBV vaccination coverage rate was 90.7% [in a remote district]. HBV vaccination coverage was at an acceptable level in Iranian children

Hepatitis B vaccination in prisons / Niyi Awofeso
Awofeso, Niyi ( 2002 )
Hepatitis B vaccine freezing in the Indonesian cold chain : evidence and solutions Carib M. Nelson ... [et al.]
Nelson, Carib M; Wibisono, Hariadi; Purwanto, Hary; Mansyur, Isa; Moniaga, Vanda; Widjaya, Anton ( 2004 )
Hepatitis B vaccines: WHO position paper – July 2017 – Vaccins anti-hépatite B: note de synthèse de l’OMS – juillet 2017
World Health Organization = Organisation mondiale de la Santé ( 2017-07-07 )
Home delivery of heat-stable vaccines in Indonesia : outreach immunization with a prefilled, single-use injection device / A. Sutanto ... [et al.]
Sutanto, A; Suarnawa, I. M; Nelson, C. M; Stewart, T; Indijati Soewarso, T ( 1999 )
Immunization of children at risk of infection with human immunodeficiency virus / William J. Moss, C. John Clements and Neal A. Halsey
Moss, William J; Clements, C. John; Halsey, Neal A ( 2003 )
The immunological basis for immunization series: module 22: hepatitis B
World Health Organization ( 2011 )
Improving birth dose coverage of hepatitis B vaccine / David B. Hipgrave, James E. Maynard and Beverley-Ann Biggs
Hipgrave, David Barry; Maynard, James E; Biggs, Beverley-Ann ( 2006 )
Infant immunization coverage in Italy : estimates by simultaneous EPI cluster surveys of regions / S. Salmaso ... [et al.]
Salmaso, Stefania; Rota, M. C; Ciofi Degli Atti, M. I; Tozzi, A. E; Kreidl, P; ICONA Study Group ( 1999 )
Showing results 1 to 20 of 48  next >